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CHIMERIC ISOPRENOID SYNTHASES AND
USES THEREOF

de?cient carbon atom resulting from the loss of the diphos
phate moiety of one substrate) to an electron-rich carbon
atom of the double bond on the IPP molecule (FIG. 2). The
electrophilic nature of these reactions is said to be unusual
relative to more general nucleophilic condensation reactions,

CROSS-REFERENCE TO RELATED
APPLICATIONS

but this appears to be a common reaction among isoprenoid

This application is a continuation of US. Ser. No. 11/932,
489, ?led Oct. 31, 2007 now abandoned, which is a continu
ation ofU.S. Ser. No. 10/717,500, ?led Nov. 21, 2003, which
is a continuation of US. Ser. No. 09/514,513, ?led Feb. 28,
2000 (now US. Pat. No. 7,186,891), which is a divisional of

bio synthetic enzymes and especially those enzymes involved
in catalyzing the cyclization of various isoprenoid intermedi
ates (Gershenzon and Croteau, In: Lipid Metabolism in
Plants, Moore, T. S., ed., CRC Press, Boca Raton, Fla., pp.
340-388). The enzymes responsible for the cyclization of

US. Ser. No. 09/134,699, ?ledAug. 14, 1998 (now US. Pat.

GPP, FPP, and GGPP are referred to as monoterpene, sesquit

No. 6,072,045), which is a continuation of US. Ser. No.

erpene, and diterpene synthases or synthases, and represent
reactions committing carbon from the general isoprenoid
pathway to end products in the monoterpene, sesquiterpene,

08/631,341, ?led Apr. 12, 1996 (now US. Pat. No. 5,824,

774).

and diterpene classes, respectively.
Two important biochemical distinctions between the pre
nyltransferase and synthase reactions are illustrated in FIG. 2.

STATEMENT AS TO FEDERALLY SPONSORED
RESEARCH

This invention was made in part with Government funding,
and the Government therefore has certain rights in the inven
tion.

20

catalyze an intramolecular carbon-carbon bond formation.

The prenyltransferases also catalyze reactions with very little
variance in the stereochemistry or length of the ensuing poly
mer. Prenyltransferases differ in the length of the allyic sub

BACKGROUND OF THE INVENTION
25

This invention relates to modi?ed isoprenoid synthase
enzymes, their encoding genes, and uses thereof.
The term isoprenoid is used to refer to a family of com

pounds derived from the isoprene building block. In particu
lar, plant isoprenoids comprise a structurally diverse group of

30

compounds that can be divided into classes of primary and

secondary metabolites (FIG. 1). Isoprenoids that are primary
metabolites include sterols, carotenoids, growth regulators,
and the polyprenol substituents of dolichols, quinones, and
proteins. These compounds are essential for membrane integ
rity, photoprotection, orchestration of developmental pro
grams, and anchoring essential biochemical functions to spe
ci?c membrane systems, respectively. Isoprenoids that are
classi?ed as secondary metabolites include monoterpenes,
sesquiterpenes, and diterpenes. These compounds are said to
mediate important interactions between plants and their envi
ronment. For example, speci?c terpenoids have been corre

35

The biosynthesis of isoprenoids such as cyclic terpenes is
said to be determined by key branch point enzymes referred to
as terpene synthases. The reactions catalyzed by terpene syn
thases are complex, intramolecular cyclizations that may
synthases are shown in FIG. 3. In step 1, the initial ionization
of FPP is followed by an intramolecular electrophillic attack

between the carbon bearing the diphosphate moiety and the
40

distal double bond to form germacene A, a macrocylic inter
mediate. Intemal ring closure and formation of the eudes
mane carbonium ion constitutes step 2. For tobacco 5-epi
aristolochene synthase (TEAS), the terminal step is a hydride

shift, methyl migration, and deprotonation at C9 giving rise to
5-epi-aristolochene as depicted in step 3a. Hyoscyamus muti
45

Nature 302:608, 1983), and plant-pathogen interactions

(Stoessl et al., Phytochemistry 15:855, 1976).

cus vetispiradiene synthase (HVS) shares a common mecha
nism at steps 1 and 2, but differs from TEAS in the third
partial reaction in which a ring contraction would occur due to
alternative migration of an electron pair. In each case, a

monomeric protein of approximately 64 kD catalyzes the

The common denominator for this diverse array of com

pounds is their universal ?ve-carbon building block, iso
prene. The “biogenic isoprene rule” was employed to ratio

strates that can be accepted in initiating these reactions. The
synthases are also substrate speci?c. However, diverse ses
quiterpene synthases, for example, can utilize the same sub
strate to produce different reaction products.

involve several partial reactions. For example, the bioorganic
rationale for the cyclization of FPP by two sesquiterpene

lated with plant-plant (Stevens, In: Isopentoids in Plants,
Nes, W. D. Fuller, G., and Tsai, L.-S., eds., Marcel Dekker,

NewYork, pp. 65-80, 1984), plant-insect (Gibson and Pickett,

The prenyltransferases catalyze carbon carbon bond forma
tion between two substrate molecules, whereas the synthases

complete set of partial reactions and requires no cofactors
50

other than Mg+2.

nalize the biosynthetic origins of all terpenoids derived from

isoprene (Ruzicka, Experientia 10:357, 1953). The polymer

SUMMARY OF THE INVENTION

ization of two diphosphorylated isoprene building blocks

(e.g., IPP and dimethylallyl) generates geranyl diphosphate
(GPP), a linear C10 intermediate that can be converted to

55

cyclic or linear end-products representing the monoterpenes,

heterologous isoprenoid synthase, whereby the chimeric iso
prenoid synthase is capable of catalyzing the production of

or used in another round of polymerization. The addition of a

third isoprene unit to GPP generates farnesyl diphosphate
(FPP), which can also be converted to cyclic or linear prod

ucts representing the sesquiterpene class. Continuing the
polymerization and chemical differentiation cycle leads to
the production of other classes of terpenoids named accord
ing to the number of isoprene building blocks leading to their

60

These polymerization reactions are catalyzed by prenyl
transferases that direct the attack of a carbocation (an electron

isoprenoid reaction products that are not produced in the
absence of the second domain of the second, heterologous

isoprenoid synthase. In preferred embodiments, the chimeric
isoprenoid synthase is capable of catalyzing at least two dif
ferent isoprenoid reaction products; the isoprenoid reaction
products are cyclic; the second domain of the second, heter

biosynthesis, for example, the addition of a third IPP to FPP

generates geranylgeranyl diphosphate (GGPP).

In general, the invention features a chimeric isoprenoid
synthase polypeptide including a ?rst domain from a ?rst
isoprenoid synthase joined to a second domain from a second,

65

ologous isoprenoid synthase also determines the ratio of the
isoprenoid reaction products of the chimeric isoprenoid syn
thase; the ?rst domain from the ?rst isoprenoid synthase is a
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plant isoprenoid synthase and the second domain from the
second, heterologous isoprenoid synthase is also from a plant

1993; Facchini and Chappell, Proc. Natl. Acad. Sci.

isoprenoid synthase.

89111088, 1992; Back and Chappell, JBiol. Chem. 27017375,
1995; Colby et al., J Biol. Chem. 268123016, 1993; Mau and

Preferably, the chimeric isoprenoid synthase is chosen
from the group consisting of (a) the tobacco-Hyoscyamus

West, Proc. Natl. Acad. Sci. 9118497, 1994; Chen et al., Arch.
Biochein. Biophys. 3241255, 1994; and Cane et al., Biochem

CH4 chimeric isoprenoid synthase; (b) the tobacco-Hyoscya

istry 3315846, 1994).

mus CH10 chimeric isoprenoid synthase; (c) the tobacco

By “polypeptide” or “protein” is meant any chain of amino

Hyoscyamus CH11 chimeric isoprenoid synthase; (d) the
tobacco-Hyoscyamus CH12 chimeric isoprenoid synthase;
(e) the tobacco-Hyoscyamus CH13 chimeric isoprenoid syn

acids, regardless of length or post-translational modi?cation

thase; or (f) the tobacco-Hyoscyamus CH14 chimeric iso
prenoid synthase, all as described herein.
In preferred embodiments, the chimeric isoprenoid syn
thase catalyzes the production of an isoprenoid reaction prod
uct that is of agricultural, pharmaceutical, commercial, or
industrial signi?cance (e.g., an antifungal agent, antibacterial
agent, or antitumor agent).

or indirectly (i.e., the domains are separated by an intervening
amino acid sequence). Such domains may be bonded by any
means, including, without limitation, a peptide bond or

(for example, glycosylation or phosphorylation).
By “joined to” is meant covalently bonded either directly

chemical linkage.
By “domain” is meant a contiguous stretch of amino acids
within a polypeptide or protein.

By “isoprenoid” is meant a compound that is derived from
an isoprene building block. In particular, isoprenoid com

In other related aspects, the invention features DNA, vec

tors, and cells (for example, E. coli, Saccharomyces cerevi
siae, animal or plant cells) encoding or containing a chimeric

pounds include, without limitation, monoterpenes, diterpe
20

isoprenoid synthase polypeptide.
In another aspect, the invention features a chimeric iso

animal, fungal, or bacterial sources.

prenoid synthase polypeptide including an asymmetrically
positioned homologous domain whereby the chimeric iso
prenoid synthase is capable of catalyzing the production of

By “asymmetrically positioned” is meant located within
the chimeric polypeptide at a site which differs from its posi
25

isoprenoid reaction products (preferably, cyclic products)

tion in the naturally-occurring polypeptide.
By “heterologous” is meant derived from different sources

when the domain is positioned at its naturally-occurring site

(in this case, different polypeptides).

in the isoprenoid synthase polypeptide.

By “homologous” is meant derived from the same source

In another aspect, the invention features a method for pro

ducing a chimeric isoprenoid synthase polypeptide, the

nes, sesquiterpenes, and sterols. As described herein, iso
prenoids are found in a variety of organisms, for example,

30

(in this case, the same polypeptide).
Other features and advantages of the invention will be

method involving: (a) providing a cell transformed with DNA

apparent from the following description of the preferred

encoding a chimeric isoprenoid synthase positioned for
expression in the cell; (b) culturing the transformed cell under
conditions for expressing the DNA; and (c) recovering the
chimeric isoprenoid synthase.

embodiments thereof, and from the claims.

By “isoprenoid synthase” is meant a polypeptide that is
capable of catalyzing a reaction involving the intramolecular
carbon-carbon bond formation of an allylic diphosphate sub
strate (for example, a C10, C15, or C2O allylic diphosphate
substrate) to an isoprenoid product (for example, a monoter
pene, diterpene, sesquiterpene, or sterol product). Examples

DETAILED DESCRIPTION
35

The drawings will be ?rst described.

Drawings
FIG. 1 is a schematic illustration showing the isoprenoid

biosynthetic pathway with respect to the type of end products
40

of such isoprenoid synthases include, without limitation,

FIG. 2 is a schematic illustration showing the various reac

monoterpene synthases (for example, limonene synthase),
diterpene synthases (for example, casbene synthase), and

sesquiterpene synthases (for example, 5-epi-aristolochene

tions that are catalyzed by prenyltransferases and terpene

synthases.
45

synthase, vetispiradiene synthase, and cadinene synthase)

(GPP), famesyl diphosphate (FPP), and geranylgeranyl
diphosphate (GGPP), respectively. A number of terpene syn

thases. Partial reactions 1 and 2 are considered common to
50

and characterized (see, for example, Moestra and West, Arch.
Biochem. Biophys. 2381325, 1985; Hohn and Van Middles
worth, Arch. Biochem. Biophys. 2511756, 1986; Hohn and
Plattner, Arch. Biochem. Biophys. 2721137, 1989; Cane and

Pargellis, Arch. Biochem. Biophys. 2541421, 1987; Munck
and Croteau, Arch. Biochem. Biophys. 282158, 1990; Alonso
et al., J Biol. Chem. 26717582, 1992; Savage et al., J Biol.

reactions 3a and 3b are suf?cient to account for the different

FIG. 4A is a schematic illustration showing the chimeric
constructs used to map catalytic domains within sesquiter
55

sesquiterpene synthase genes that were engineered into the
prepared using a combination of the available restriction
60

endonuclease sites and ampli?cation of select regions using
PCR and PCR primers harboring convenient restriction endo
nuclease sites. Correspondence between unique restriction
endonuclease sites and amino acid positions are noted.
FIG. 4B is a photograph of a TLC experiment showing

molecular weight of about 40 to 100 kD. Genes encoding a

number of monoterpene, diterpene, and sesquiterpene syn

bial organisms (see, for example, Hohn and Beremand, Gene
791131, 1989; Proctor and Hohn, JBiol. Chem. 26814543,

pene synthases. Line drawings depict composite diagrams for
wildtype (i.e., TEAS and HVS) and chimeric (CH1-CH14)
bacterial expression vector pGBT-T19. Gene constructs were

phys. 3091184, 1994; Vogeli et al., Plant Physiol. 931182,

thases have been described for a number of plant and micro

both types of synthases. Mechanistic differences in partial

reaction products shown.

Chem. 26914012, 1994; Croteau et al., Arch. Biochem. Bio

1990; Guo et al., Arch. Biochem. Biophys. 3081103, 1994; and
Gambliel and Croteau, J Biol. Chem. 2591740, 1984). In
general, terpene synthases are soluble enzymes having a

FIG. 3 is a schematic illustration showing a reaction

mechanism for the synthesis of eremophilane (tobacco 5-epi
aristolochene synthase, TEAS) and vetispiradiene (Hyoscya
mus vetispiradiene synthase, HVS) type sesquiterpene syn

that are responsible for cyclization of geranyl diphosphate
thases from plant and microbial sources have been isolated

and their respective physiological functions. Broken arrows
indicate multiple steps or reactions.

65

synthase enzyme activities in sonicated lysates of E. coli TB1
cells expressing the TEAS, HVS, and chimeric synthase con
structs (CH1-CH14) and measured using .sup.3H-FPP. Reac
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tion products were separated by argentation-TLC and

with the 3' terminal portion of TEAS gene (corresponding to

detected by autoradiography. The radioactivity in 0.5 mm

the Hindlll to Kpnl fragment) into pGBT-T19.
CH7 was prepared by ligating the 5' terminal portion of the

segments of each lane of an argentation-TLC plate was deter
mined in a scintillation counter, and radioactivity associated
with the zones for the TEAS and HVS speci?c products was

HVS gene (corresponding to the EcoRI to Ndel fragment)
with the 3' terminal portion of TEAS gene (corresponding to

set to 100%.

the Ndel to Kpnl fragment) into pGBT-T19.
CH3, CH4, CH12, and CH13 were constructed using con

FIG. 5 is a schematic illustration showing the correspon
dence between exons and functional domains within iso

ventional polymerase chain reaction (PCR) methodologies,
with primers designed for the ampli?cation of particular seg

prenoid synthases. The upper diagram represents the organi
zation of exons within the TEAS gene, which is nearly
identical to that of the HVS and casbene synthase genes. The
lower diagram shows the alignment of functional domains to
the exonic organization of the TEAS and HVS genes. Exon
numbers are shown within the upper diagram, and all other

ments of the HVS gene. To facilitate directional cloning and

numbers refer to amino acid positions, some of which corre

Clal/Kpnl fragment of the HVS gene. The HVS Clal/Kpnl

spond to the noted restriction endonuclease sites.
FIG. 6 is a schematic diagram showing a domain switching

fragment was prepared by PCR methodology using 5'-d

strategy used to generate a quiescent synthase (QH1). Sub

ID NO: 1; Clal restriction site underlined) as the forward

stituting the inactive HVS domain corresponding to exon 4
into CH3 results in a synthase having an altered enzyme

maintenance of reading frame, primers were also designed to
contain convenient restriction sites.
CH3 was constructed as follows.An EcoRl/Clal restriction

fragment of the TEAS gene was isolated and ligated to the

(GGGATCGATGACATAGCCACGTATGAGGTT)-3' (SEQ
primer and 5'-d (AATACGACTCACTATAG)-3' (SEQ ID
20

activity.

NO: 2) as the reverse primer (corresponding to the T7

sequence found in the multiple cloning site of pBSK) using
pBSK-HVS as the DNA template. The resulting restriction
fragment was ligated into the EcoRl/Kpnl sites of the pGBT

FIG. 7 is a schematic diagram of a domain switching strat

egy used for producing a chimeric quiescent-casbene syn

thase, and possible reaction products.
FIG. 8 is a schematic illustration of a domain switching

25

using the forward ampli?cation primers 5'-d(CGA
GTCAACATGGTTTATTGAGGGATA)-3' (SEQ ID NO: 3;

strategy for producing a chimeric quiescent-cadinene syn

thase, and possible reaction products.
CHIMERIC ISOPRENOID SYNTHASES
30

Plasmids designed for expressing a chimeric synthase were

portion of a gene encoding a domain from Hyoscyamus
35

sesquiterpene synthase activity. The sesquiterpene synthase

5'-d(GGGAGCTC

NO: 6; C al restriction site underlined).

Chimeric synthases CH6, CH8, CH9, CH10, CH11, and
CH14 were constructed as follows. Ligation of the EcoRI/

Full-length cDNAs for the tobacco 5-epi-aristolochene
45

(HVS) were cloned into the EcoRl/Xhol sites of pBluescript

SK (Stratagene), creating the pBSK-TEAS and pBSK-HVS
plasmids, respectively (Back and Chappell, J Biol. Chem.

vector pGBT-T19 (Gold Biotechnology) predigested with

primer

ATCGATAACTCTGCATAATGTAGCATT)-3' (SEQ ID
40

as follows.

270:7375, 1995). The TEAS and HVS cDNA inserts ofthese
expression plasmids were oriented with their translation start
codons neighboring the EcoRI restriction site and their 3' poly
A tail ?anked by the Xhol restriction site of the pSK plasmid.
Chimeric synthases CH1, CH2, CH5, and CH7 were con
structed by utilizing the conserved Hindlll and Ndel restric
tion sites found between the tobacco and Hyoscyamus genes.
CH1 was prepared by ligating the 5' terminal portion of the
TEAS gene (corresponding to the EcoRI to Hindlll fragment)
with the 3' terminal portion of HVS gene (corresponding to
the Hindlll to Kpnl fragment) into the bacterial expression

ampli?cation

(SEQ ID NO: 5; EcoRl restriction site underlined and trans
lation start codon in bold) and reverse primer 5'-d(GGG

Chem. 270:7375, 1995). As shown in FIG. 4A, fourteen chi
meric synthase constructs were generated and were assayed

synthase (TEAS) and Hyoscyamus vetispiradiene synthase

forward

GAATTCCATGGCCTCAGCAGCAGTTGCAAACTAT)-3'

assays included an argentation-thin layer chromatography
(TLC) analysis which distinguished the aristocholene and

vetispiradiene reaction products (Back and Chappell, J. Biol.

H1ncll restriction site underlined) and 5'-d(TAT
TCTAGATCTCTATGACGATTATGAA)-3' (SEQ ID NO: 4;
Xbal restriction site underlined), respectively.
CH12 was prepared by ligating a PCR fragment corre
sponding to the ?rst 1326 nucleotides of CH4 with the Clal/
Kpnl fragment of the TEAS gene into the EcoRl/Kpnl sites of
the pGBT-T19 vector. The CH4 fragment was prepared using

generated by substituting a portion of a gene encoding a
domain from tobacco 5-epi-aristolochene synthase with a

vetispiradiene synthase. These plasmids were expressed in
bacteria, and bacterial lysates were prepared and assayed for

T19 vector.
CH4 and CH13 were constructed in a similar manner, but

50
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Hindlll fragment of the HVS gene with the Hindlll/Kpnl
fragment of CH3 generated CH6. CH8 was created by ligat
ing the EcoRl/Ndel fragment of HVS with the Ndel/Kpnl
fragment of CH3. CH9 was created by ligating the EcoRI/
Ndel fragment of CH5 with the Ndel/Kpnl fragment of HVS.
CH10 was constructed by ligating the EcoRl/Hindlll frag
ment of HVS with the Hindlll/Kpnl fragment of CH4. CH11
was constructed by ligating the EcoRl/Ndel fragment of HVS
with the Ndel/Kpnl fragment of CH4. And CH14 was gener
ated by substituting the EcoRl/Ndel fragment of CH13 with
the corresponding DNA fragment of pBSK-HVS. The nucle
otide junctions of the chimeric constructs were con?rmed by

double-stranded DNA sequencing using the dideoxy nucle
otide chain termination kit, according to the manufacturer’s

instructions (U .S. Biochemical Corp).
Chimeric synthases were expressed in E. coli TB1 cells.
Procedures for growth of the bacterial cells, induction of gene
60

expression, measurement of sesquiterpene synthase enzyme

EcoRI and Kpnl.
CH2 was prepared by ligating the 5' terminal portion of the

activity, and the determination of total protein in the bacterial
lysates were performed according to the methods described

TEAS gene (corresponding to the EcoRI to Ndel fragment)
with the 3' terminal portion of HVS gene (corresponding to

by Back and Chappell (Arch. Biochem. Biophys. 315:527,
1994; J. Biol. Chem. 270:7375, 1995). Reaction products
were separated by developing G60 silica TLC plates impreg

the Ndel to Kpnl fragment) into pGBT-T19.
CH5 was prepared by ligating the 5' terminal portion of the
HVS gene (corresponding to the EcoRI to Hindlll fragment)

65

nated with 1 5% silver nitrate in benzene:hexane: diethyl ether

(50:5011). For qualitative evaluations, TLC plates were
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sprayed with Enhance surface ?uorography spray (Dupont)

resulted in the production of an enzyme having HVS- and
TEAS-speci?city. CH12 represented a substitution of the
Hindi to ClaI fragment of the tobacco gene with the corre

and exposed to Kodak XAR-5 ?lm for 2 to 5 days at —700 C.
For quantitative evaluations, 0.5 mm zones of an entire lane

sponding Hyoscyamus gene fragment, and resulted in the
production of an enzyme having HVS- and TEAS-speci?city.

from a TLC plates were scraped into scintillation vials, and
the radioactivity was determinedusing a Packard 1500 Liquid
Scintillation Counter. The dominant reaction products gener

Comparing CH11 to CH13 provided a further re?nement in
the domain characterization of the tobacco enzyme respon
sible for the TEAS-speci?c products. The fact that CH13 was
found to be a multifunctional enzyme indicated that the 81

ated by the synthase activities resulting from expression of
the TEAS, HVS, CH4, and CH14 constructs in bacterial
lysates were also veri?ed by gas chromatography (GC) and

gas chromatography-mass spectroscopy (GC-MS) according

amino acids encoded by the DNA fragment residing between

to the conditions described by Chappell et al. (Phylochemis
try 2612259, 1987) (data not shown). In addition, mass spectra
pro?les were compared to that published for 5-epi-aris
tolochene (Anke and Sterner, Planta Med. 571344, 1991) and

the NdeI to XbaI restriction sites of the tobacco cDNA were

suf?cient for formation of the predominant TEAS speci?c
products. This interpretation was con?rmed by substituting

the predicted fragmentation pattern for vetispiradiene (Enzell

the domain contained within the NdeI/XbaI HVS cDNA
restriction fragment of CH14 with that of the TEAS gene

et al., Mass Spectrometry Rev. 31395, 1984).

(FIG. 4A).

As shown in FIGS. 4A-B, the dominant reaction product
resulting from the expression of the tobacco TEAS gene
expressed was 5-epi-aristolochene, and vetispiradiene was
found to be the dominant reaction product resulting from the
expression of the HVS gene. The predominant reaction prod
ucts generated by the expression of CH1 and CH2 were also

As shown in FIG. 4B, the predominant reaction product(s)
of the wildtype tobacco TEAS and Hyoscyamus HVS genes
expressed in bacteria migrated on silver nitrate-TLC plates
with Rfvalues of 0.41 and 0.31, values consistent with previ

20

ous characterization of these products as 5-epi-aristolochene

and vetispiradiene, respectively (Back and Chappell, J Biol.

HVS-speci?c (i.e., vetispiradiene), with enzyme speci?c
activities similar to those found for HVS that was expressed

from the pBSK-HVS plasmid. These results indicated that the

25

amino-terminal half of TEAS and HVS were functionally

equivalent with respect to the HVS carboxy-terminus and do
not contribute to the speci?city of the reaction product. CH7,
having an HVS amino terminus and a TEAS carboxy termi
nus, is the converse construct of CH2, and the resulting syn
thase activity was expected to result in expression of a TEAS

30

Chem. 27017375, 1995; Back et al., Arch. Biochem. Biophys.
3151527, 1994). GC and GC-MS analyses indicated that the
predominant TEAS reaction products were 5-epi-aris
tolochene (70% of total products, based on percentage of total
peak areas from GC analysis) and a bicyclic sesquiterpene
(20%) ([M]+ ion at m/z of 204). The predominant HVS reac
tion product was vetispiradiene (>90%) ([M]+ ion at m/z of
204 with a base peak at m/z 41 and a series of predictable ions

speci?c product (i.e., 5-epi-aristolochene). Immunodetection

at m/z 175, 108, 94, and 68), and the predominant reaction
products of CH4 were 5-epi-aristolochene (18%), a bicyclic

assays revealed that synthase protein produced upon expres

sesquiterpene (43%), and vetispiradiene (32%) (data not

shown).

sion of CH7 was found to be of the correct size and expected

abundance (data not shown); however, no enzyme activity

35

was detected. The lack of enzyme activity indicated that
interactions between the carboxy and amino terminal por

tions of the protein contributed to enzyme activity. This inter
40

mately 1% of the total products, with all ?ve found at the same
relative abundance in all the reaction assays.
Ratio-Determinant Domain

45

Another domain of the synthase proteins was identi?ed by
comparing the relative ratio of the predominant reaction prod
ucts produced by the multifunctional chimeric synthase
enzymes (FIG. 4A). For example, the reaction products
resulting from expression of constructs CH4, CH10, CH11,

pretation is further supported by comparing the speci?c activ
ity of the enzymes generated by the expression of the CH5
and CH6 constructs. CH5 resulted in the expression of a

product having a 10-fold lower speci?c activity of synthase
enzyme activity than the other chimeric synthases, even
though the absolute level of expressed protein was similar to
the other constructs (as determined by immunodetection, data

not shown). Substituting an HVS carboxy-terminal region

and CH12 were generated in a ratio of 60-70% TEAS-speci?c
to 30-40% HVS-speci?c. In contrast, an inverse ratio of reac

was found to restore the speci?c activity to the synthase
enzyme that was generated by CH6.

Comparison of CH2 and CH3 chimeric synthases provided
evidence for speci?city of end-product formation residing

50

synthase enzymes. These results indicated that two separate
and distinct domains within the synthase peptide contributed
directly to the types of reaction products generated, and are
55

aristolochene synthase are responsible for the TEAS-speci?c
products (i.e., the region corresponding to the NdeI to HindIII

the Hyoscyamus protein are responsible for the HVS-speci?c
products (i.e., the region corresponding to the HincII to ClaI
fragment of the cDNA).
Our interpretation was con?rmed by evaluating the expres
sion products of CH11 and CH12. CH11 represented the
substitution of the NdeI to Hindi fragment of the Hyoscyamus
gene with the corresponding tobacco gene fragment, and

interrupted by another domain which we refer to as the ratio

determinant domain (FIG. 5).
Site-Directed Mutagenesis
Additional analysis of the product speci?city and ratio

TEAS and HVS enzymes. We interpreted this result to indi
cate that amino acids 261 to 379 within the tobacco 5-epi

fragment of the cDNA), while amino acids 379 to 442 within

tion products resulted from expression of constructs CH13
and CH14. This result indicated that the region encompassed
by the XbaI to HincII domain in?uenced the relative ratio of

reaction products generated by the multifunctional chimeric

within a domain of approximately 181 amino acids, corre
sponding to the NdeI and ClaI restriction sites within the

TEAS and HVS genes. Expression of CH4 unexpectedly
resulted in the production of a chimeric synthase protein
capable of generating reaction products re?ective of both the

In addition, studies relying on af?nity puri?cation of his
tidine-tagged recombinant synthase proteins has revealed ?ve
other minor reaction products, each representing approxi

determinant domains was determined using conventional
60

site-directed mutagenesis methodologies. The results of this
analysis are presented in Table I (below). For example, the
DDXXD motif, found within the aristolochene speci?c
domain, is a conserved sequence that is found in a variety of

terpene biosynthetic enzymes including TEAS and HVS.
65

This acidic amino acid cluster is said to coordinate a metal

cofactor that is necessary to neutralize the diphosphate moi
ety of FPP in an otherwise lipophilic pocket. Substitution of
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the ?rst aspartic acid residue (D301) of the DDXXD motif

the primers, is substituted for the corresponding region of

with either glutamic acid (overall charge conservation) or
valine (net loss of acidic charge) residues (i.e., D301QE and

CH3. In generating such constructs, care is exercised to main

D301QV) resulted in the formation of an inactivated
enzyme. A conserved substitution of the second aspartic acid

tain appropriate amino acid residues and the correct reading
frame, and expression testing of the construct entails a mea
surement of the protein level in the soluble and insoluble

(D302) with a glutamic acid residue (i.e., D302—>E) also
inactivated chimeric synthase enzyme activity by 95%, and

as well as by enzyme assays.

fractions of bacterial lysates by immunoblotting techniques,

resulted in a slight alteration of the product distribution of the
multifunctional enzyme.

In addition, large scale enzyme reactions are performed,
the reaction product(s) are extracted into hexane, and the
products are puri?ed by HPLC methods. Additional evalua
tion of the quiescent enzyme reaction products is carried out

TABLE I
Mutation
target

Mutated
amino

gene

acid

Aristolochene

Vetispiradiene

66%

34%

CH4

using TLC, and comparing the Rfvalues of the experimental

Speci?c
Activity

Product ratio

(nmol/mg hil)

sample to those generated by the TEAS and HVS enzymes.
Retention times of the reaction products (e.g., gerrnacrene or
15

34

Substrate binding domain (Ndel/Xbal region)
Tobacco
CH4
CH4
CH4
CH4

D301V
R287A
D301V
D301E

No
No
No
No

D302E

activity
activity
activity
activity
51%

0
0
0
0
49%

20

1.8

Ratio determinant domain (Xbal/HincII region)
CH4
CH4
CH4

K3471
H360S
H364S

64%
63%
65%

3 6%
32%
35%

32
29
38

ing novel macrocyclic isoprenoids or isoprenoids having
altered stereochemical properties. For example, isoprenoid
synthases such as casbene synthase, a diterpene synthase
which catalyzes the synthesis of a macrocyclic diterpene

Hyoscyamus speci?c domain (HincIUClaI region)
CH4
CH4
CH4
CH4

T408A
K420M
H422A
N436S

67%
68%
67%
70%

33%
32%
33%
30%

48
29
30
32

CH4

AT437,

61%

39%

33

harboring a cyclopropyl side group, and cadiene synthase, a

sesquiterpene synthase that catalyzes the synthesis of a bicy
clic sesquiterpene, provide domains useful for engineering
enzymes capable of producing macrocylic isoprenoids or
isoprenoid reaction products having altered sterochemical
properties. A general scheme for producing such chimeric

43 8V1

The sites for directed substitutions within the ratio-deter

minant domain (i.e., K347—>I, H360QS, H364QS) were
inferred by an analysis of reports that hypothesized the impor
tance of charged amino acid residues (e.g., histidine or lysine)
in synthase enzymology, and these sites represented those
amino acids which displayed the greatest charge differences
in comparisons between the TEAS and HVS primary
sequences. None of the three mutations analyzed had any
effect on overall catalytic activity or the ratio of products
formed.
Amino acid substitutions within the HVS speci?c domain
were chosen on the basis of comparisons between secondary
structural predictions of the HVS and TEAS proteins. Those
amino acids mutated appeared to contribute disproportion
ately to structural distortions in the secondary structure mod

els of these two proteins, largely because of charge consider

germacrene-like reaction product) are also monitored using
GC, GC-MS, and NMR according to standard methods.
The quiescent synthase is useful for providing suf?cient
amounts of the gerrnacrene reaction intermediate(s) (or
derivatives thereof) to con?rming the chemical rationaliza
tion for the EAS and VS reactions, and produces a template
chimeric synthase that may be used for the introduction of
novel terminal steps in the overall synthase reaction scheme.
Chimeric Casbene and Cadinene Synthases
Chimeric isoprenoid synthases are also useful for generat

35

synthases is presented in FIGS. 7 and 8.
To construct such chimeric casbene and cadienne syn

thases, quiescent amino terminal domains (and other syn
thase domains, as necessary) are substituted with those from

casbene and cadinene synthase using convenient restriction
40

sites and PCR ampli?cation of selected regions as described

above. Sequences corresponding to the N-terminal, plastid
targeting sequence of the casbene synthase are deleted in
these constructs. Chimeric constructs are expressed in bacte

ria, bacterial lysates are examined for chimeric synthase
45

activity, and reaction products are characterized as described

above, for example, using argentation-TLC. Constructs sup
porting high levels of synthase activity in bacteria and/or
activity generating reaction products which migrate with Rfs
50

different from aristolochene and vetispiradiene standards are
considered useful in the invention. Reaction products are also

ations. However, as shown in Table I (above), substitutions

analyzed for their retention times by GC and subjected to

involving charged to non-charged (i.e., T408QA, K420—>M,

GC-MS and NMR, as necessary. Those domains of casbene

H422QA) or reduced charged (N436QS, A437—>T,

synthase and cadinene synthase which contribute to the syn
thesis of unique reaction products may also be subjected to
?ne detail mapping using a strategy analogous to that
depicted in FIG. 4A.
Production of Other Chimeric Isoprenoid Synthases
Using the standard molecular techniques described herein,
other chimeric synthases may be readily generated which
include domains from known or newly isolated synthase
enzymes. Such chimeric synthases may be tested for activity
using, for example, any appropriate enzyme assays known to
those in the art, or by standard immunodetection techniques.
The isolation of additional synthase coding sequences is

V438—>I) amino acids did not affect overall enzyme activity,
nor the synthesis rate of one product or the other.
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Quiescent Synthases
To generate a quiescent synthase, the inactive domain cor
responding to exon 4 of HVS is substituted with the corre

sponding active domain of CH3, as outlined in FIG. 6. CH3
contains an inactive domain corresponding to exon 6 of
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TEAS, has convenient NdeI and XbaI restriction sites for the
desired substitution, and can be overexpressed in bacteria to

high levels. Domain switching is accomplished using stan
dard molecular techniques, as described herein. In one par

ticular example, a PCR ampli?cation product of HVS cDNA
corresponding to exon 4, encompassing amino acids 261 to
342 and containing appropriate NdeI and XbaI sites within
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also possible using standard cloning strategies and techniques
that are well known in the art. For example, using all or a

portion of the amino acid sequence of a known synthase

